*nlm.life
			PubMed Journals: Euro Surveill

  Source:		PMID: 32070465


    		Euro Surveill. 2020 Feb;25(6). doi:
     		10.2807/1560-7917.ES.2020.25.6.2000094.

			First cases of coronavirus disease 2019
			(COVID-19) in France: surveillance,
			investigations and control measures, January
			2020.

			Bernard Stoecklin S(1), Rolland P(2), Silue Y(3),
			Mailles A(1), Campese C(1), Simondon A(4),
			Mechain M(5), Meurice L(6), Nguyen M(5), Bassi
			C(3), Yamani E(4), Behillil S(7), Ismael S(8),
			Nguyen D(9), Malvy D(10)(9), Lescure FX(11)(8),
			Georges S(1), Lazarus C(12), Tabaï A(13),
			Stempfelet M(13), Enouf V(7), Coignard B(1),
			Levy-Bruhl D(1), Investigation Team(14).

			Author Information
			(1) Santé publique France, Direction des
			maladies infectieuses, Saint-Maurice, France.
			(2) Santé publique France, Direction des régions,
			Saint-Maurice, France.
			(3) Santé publique France, Direction des régions,
			Cellule Régionale Ile-de-France, Paris, France.
			(4) Agence Régionale de Santé Ile-de-France,
			Paris, France.
			(5) Agence Régionale de Santé
			Nouvelle-Aquitaine, Bordeaux, France.
			(6) Santé publique France, Direction des régions,
			Cellule Régionale Nouvelle-Aquitaine, Bordeaux,
			France.
			(7) Centre National de Référence des virus des
			infections respiratoires, dont la grippe,
			Institut Pasteur, Paris, France.
			(8) AP-HP, Hôpital Bichat, Service des maladies
			infectieuses et tropicales, Paris, France.
			(9) Centre Hospitalier Universitaire de Bordeaux,
			Service des maladies infectieuses et tropicales,
			Bordeaux GeoSentinel Site, Bordeaux, France.
			(10) UMR 1219, Université de Bordeaux,
			Bordeaux, France.
			(11) Université de Paris, IAME, INSERM, Paris,
			France.
			(12) Direction Générale de la Santé, Ministère des
			solidarités et de la santé, Centre opérationnel de
			réception et de régulation des urgences sanitaires
			et sociales, Paris, France.
			(13) Santé publique France, Direction alerte et
			crise, Saint-Maurice, France.
			(14) The members of the investigation team are
			listed at the end of the article.

			A novel coronavirus
			(severe acute respiratory syndrome coronavirus
			2, SARS-CoV-2) causing a cluster of
			respiratory infections (coronavirus disease
			2019, COVID-19) in Wuhan, China, was
			identified on 7 January 2020. The epidemic
			quickly disseminated from Wuhan and as at 12
			February 2020, 45,179 cases have been
			confirmed in 25 countries, including 1,116
			deaths. Strengthened surveillance was
			implemented in France on 10 January 2020 in
			order to identify imported cases early and
			prevent secondary transmission. Three
			categories of risk exposure and follow-up
			procedure were defined for contacts. Three
			cases of COVID-19 were confirmed on 24
			January, the first cases in Europe. Contact
			tracing was immediately initiated. Five contacts
			were evaluated as at low risk of exposure and
			18 at moderate/high risk. As at 12 February
			2020, two cases have been discharged and the
			third one remains symptomatic with a
			persistent cough, and no secondary
			transmission has been identified. Effective
			collaboration between all parties involved in the
			surveillance and response to emerging threats
			is required to detect imported cases early and
			to implement adequate control measures.

			
			DOI: 10.2807/1560-7917.ES.2020.25.6.2000094
			PMID: 32070465

     			                         Tweet       Print